Abstract
The process of scaling up pharmaceutical manufacturing from laboratory to commercial production presents a complex set of challenges. These challenges span technical, regulatory, logistical, and economic dimensions. While laboratory-scale formulations are meticulously designed and optimized, translating these processes to industrial scale requires careful adaptation to ensure product quality, efficacy, and regulatory compliance. This article explores the critical factors affecting scale-up including process control, equipment design, raw material variability, regulatory constraints, and supply chain limitations. Addressing these challenges is essential to ensuring successful and cost-effective pharmaceutical production that meets global standards.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Adeel Zaman (Author)